Concerning the XRCC2 Arg188His variant and clinicopathological characteristics, we did not observe a significant association between various BC clinicopathological characteristics and Arg188His polymorphism in the breast cancer patients (S1 Table). This evidence concerns the gene XRCC2 and breast carcinoma.